Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Other(1)

Detailed Status

Completed2

Recruiting2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (25.0%)

N/A3 (75.0%)

Trials by Status

completed240%

unknown120%

recruiting240%

Recent Activity

2 active trials

Showing 5 of 5

recruitingphase_1

Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers

NCT07079930

recruitingnot_applicable

Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father

NCT06772701

completed

Clinical Trials (5)

Showing 5 of 5 trials

NCT07079930Phase 1

Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers

Recruiting

NCT06772701Not Applicable

Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father

Recruiting

NCT03529513

Medibio DDA Confirmatory Performance Study

Completed

NCT03225027Not Applicable

Study on Communication Comprehension in the Schizophrenic Spectrum

Completed

NCT02834182Not Applicable

fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder

Unknown

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5